Our Commitment

The Women's Cancer Research Center (WCRC) is a collaboration between the University of Pittsburgh Cancer Institute (UPCI) and the Magee Women's Research Institute (MWRI).

The mission of the WCRC is to reduce the incidence and death from women's cancer. This mission is achieved through the development and fostering of vibrant basic, translational, and clinical research aimed at translating novel discoveries into improved patient care.

What We Do

The WCRC provides a supportive environment for a programmatic approach by basic scientists, clinician scientists, clinicians, post-doctoral and clinical fellows and graduate students. The research thrust is thoroughly integrated with the excellent basic, clinical and clinical research programs already in place. Research programs focus mainly on breast and ovarian cancer, but also include other gynecological cancers. Integrated into the research program is an education component aimed at developing the next generation of researchers and physicians in women's cancer.

Major research areas include:

  • Mechanisms of cancer initiation and progression
  • Hormone receptor action and resistance to hormone therapy
  • Risk assessment and reduction
  • Prevention
  • Molecular profiling of early disease and progression
  • Development and testing of new diagnostic, predictive, and prognostic biomarkers
  • Identification and testing of new targeted therapies
  • New imaging techniques, and integration into screening programs
  • Research on normal development of breast and ovaries
For more information, visit http://www.upci.upmc.edu/WCRC.

Education Opportunities  

Great Lakes Nuclear Receptor Meeting Registration  

The University of Pittsburgh Cancer Institute (UPCI), the Ohio State University (OSU) Comprehensive Cancer Center—James Cancer Hospital and Solove Research Institute, and the Case Comprehensive Cancer Center (Case CCC) are coming together to host the inaugural Great Lakes Breast Cancer Symposium from June 4 to 6, 2015 at Case Western Reserve University in Cleveland, Ohio. The goal of the symposium is to increase collaboration between these three cancer centers in the area of breast cancer research and clinical trials, as these organizations are located less than 200 miles from one another and have complementary strengths in basic, translational, and clinical breast cancer research.

The symposium will feature short talks on current research by faculty from each participating site, poster presentations by trainees and additional faculty, an overview of breast cancer research occurring at each participating center, and a key note address by Dr. Douglas Yee, director, University of Minnesota Masonic Cancer Center. There also is an opportunity for attendees to present their abstracts during the event.

Registration for the symposium is $100, and UPCI will provide transportation to and from the event (either by coach bus or Pitt van). To register and to submit abstract proposals, visit the symposium’s website here. If you wish to travel with the UPCI team, please email Nadine Ryan at ryann@upmc.com.

This is a great opportunity to network with outstanding breast cancer investigators in the region! Register today!